Guardant Health
GH
#2993
Rank
NZ$7.39 B
Marketcap
$59.86
Share price
-0.84%
Change (1 day)
37.98%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

We have found no dividend yield history for this company